EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Validation of the prognostic model “oncologiq palliative” for head and neck cancer patients

B N van den Besselaar iD, D van Klaveren, D Berzenji, A Hoesseini, J C Jansen, J A Hardillo, R J Baatenburg de Jong, M P J Offerman, A Sewnaik

European Archives of Oto-Rhino-Laryngology · 2025

DOI: 10.1007/s00405-025-09462-1 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift European Archives of Oto-Rhino-Laryngology, 2025. Verfasst von B N van den Besselaar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherl…. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Palliative Care, Squamous Cell Carcinoma of Head and Neck. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KWF Kankerbestrijding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Patients diagnosed with incurable head and neck squamous cell carcinoma (HNSCC) have a poor prognosis, with a median survival of approximately five months. Physicians often struggle to predict prognosis accurately and tend to overestimate survival. Timely sharing of validated accurate individual information on life expectancy could aid in facilitating better patient counseling. However, this knowledge is lacking. Therefore, the aim of this study is to conduct temporal and external validation of the prognostic model OncologIQ Palliative to assess its accuracy and generalizability.

Methods

The validation procedure involved temporal assessment in a retrospective cohort of 355 palliative HNSCC patients from Erasmus MC (2017–2020), followed by external validation in a retrospective cohort of 44 patients from Leiden University Medical Center (2019–2021).The discriminative ability of OncologIQ Palliative was assessed using the C-index and calibration was evaluated through graphical assessment, intercept, and slope.

Results

The temporal cohort had a median follow-up of 115 days, and the external cohort 143 days. The model showed moderate discriminative ability in temporal validation (C-index 0.66) and better discrimination in external validation (C-index 0.71). Reasonable agreement was observed between predicted and observed 6-month and 1-year survival rates, with some deviations from the perfect calibration line.

Conclusion

The validation methods conducted in this study underscored the reliability of OncologIQ Palliative. They showed adequate calibration and discrimination in both validation procedures, thereby facilitating the provision of more accurate prognostic counselling for head and neck cancer patients in the palliative phase.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Head and Neck NeoplasmsPalliative CareSquamous Cell Carcinoma of Head and NeckHumansMaleFemalePrognosisRetrospective StudiesMiddle AgedAgedAged, 80 and overSurvival RateAdultReproducibility of Results

Stichwörter der Autor:innen

Head and neck CancerPalliative carePersonalized prognostic counsellingProactive care planningPrognostic modellingValidation study

Autor:innen und Institutionen

  • Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands. b.vandenbesselaar@erasmusmc.nl.
  • Department of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Department of Otolaryngology and Head and Neck Surgery, Leiden University Medical Center, Leiden, The Netherlands.

ORCID-Profile: B N van den Besselaar

Förderung

  • KWF Kankerbestrijding

Zitieren

APA

van den Besselaar, B. N., van Klaveren, D., Berzenji, D., Hoesseini, A., Jansen, J. C., Hardillo, J. A., Baatenburg de Jong, R. J., Offerman, M. P. J., & Sewnaik, A. (2025). Validation of the prognostic model “oncologiq palliative” for head and neck cancer patients. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-025-09462-1

Vancouver

van den Besselaar BN, van Klaveren D, Berzenji D, Hoesseini A, Jansen JC, Hardillo JA, et al. Validation of the prognostic model “oncologiq palliative” for head and neck cancer patients. European Archives of Oto-Rhino-Laryngology. 2025. doi:10.1007/s00405-025-09462-1

BibTeX
@article{vandenBesselaar2025,
  author = {van den Besselaar, B N and van Klaveren, D and Berzenji, D and Hoesseini, A and Jansen, J C and Hardillo, J A and Baatenburg de Jong, R J and Offerman, M P J and Sewnaik, A},
  title = {Validation of the prognostic model “oncologiq palliative” for head and neck cancer patients},
  journal = {European Archives of Oto-Rhino-Laryngology},
  year = {2025},
  doi = {10.1007/s00405-025-09462-1}
}
Kostenlos starten →